Home > Boards > US Listed > Medical - Equipment > BrainsWay (BWAY)

University TMS Clinic Now Offering FDA-Cleared Helmet to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
midastouch017 Member Profile
 
Followed By 125
Posts 25,554
Boards Moderated 9
Alias Born 02/07/04
160x600 placeholder
Amended Annual and Transition Report (foreign Private Issuer) (20-f/a) Edgar (US Regulatory) - 6/17/2021 5:00:55 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/3/2021 9:31:09 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 6/3/2021 9:29:07 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/2/2021 8:00:58 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/1/2021 8:01:06 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/24/2021 8:01:03 AM
Brainsway EPS misses by $0.03, beats on revenue Seeking Alpha - 5/20/2021 8:09:26 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/20/2021 8:01:04 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/5/2021 8:00:57 AM
Tender Offer Statement by Issuer (sc To-i) Edgar (US Regulatory) - 5/4/2021 9:29:32 AM
BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month GlobeNewswire Inc. - 5/4/2021 9:02:00 AM
BrainsWay launches noninvasive treatment for smoking addiction Seeking Alpha - 4/29/2021 9:10:50 AM
BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers GlobeNewswire Inc. - 4/29/2021 9:03:00 AM
RIOT, MARA, OCGN and MVIS among notable premarket gainers Seeking Alpha - 4/26/2021 8:21:35 AM
BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment Seeking Alpha - 4/26/2021 7:43:06 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/26/2021 7:30:54 AM
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder GlobeNewswire Inc. - 4/26/2021 7:30:00 AM
BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS) GlobeNewswire Inc. - 4/14/2021 9:03:00 AM
Brainsway EPS beats by $0.03, beats on revenue Seeking Alpha - 3/24/2021 4:24:50 PM
BrainsWay Ltd. Announces Closing of $45.2 Million Underwritten Public Offering of American Depositary Shares Including Full E... GlobeNewswire Inc. - 3/1/2021 7:00:00 AM
BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares GlobeNewswire Inc. - 2/23/2021 8:30:00 AM
BrainsWay readies ADS offering Seeking Alpha - 2/22/2021 4:06:39 PM
BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 2/22/2021 4:02:00 PM
BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales GlobeNewswire Inc. - 2/16/2021 7:30:00 AM
BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results GlobeNewswire Inc. - 2/16/2021 7:00:00 AM
midastouch017   Tuesday, 07/21/20 09:25:44 AM
Re: None
Post # of 29 
University TMS Clinic Now Offering FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disor...

July 21 2020 - 09:00AM

University TMS, a mental health facility specializing in advanced treatments for neurological and psychiatric disorders, is now offering BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) for major depressive disorder (MDD) and obsessive-compulsive disorder (OCD).
“We have learned that each year more than 20% of the Alabama population meets the requirements for a mental health diagnosis,” said Dr. Timothy Prestley, M.D., founder and neurologist at University TMS. “Our mission is to provide hope through innovative and noninvasive treatment options, such as Deep TMS. Many mental illnesses, including depression and OCD, have been exacerbated during the COVID-19 pandemic, and we want to have every tool in our belt to help those living in the Tuscaloosa County community.”

BrainsWay’s Deep TMS administers magnetic waves through a cushioned helmet to target deep structures of the brain that impact a patients’ depression and OCD symptoms. The treatment is both noninvasive and medication-free, and patients can return to normal activities, such as driving, immediately following the session. Because Deep TMS penetrates deeper and broader in the brain than traditional TMS, it enables stimulation of the deep brain structures that are involved in mental health illnesses. BrainsWay has been treating depression with Deep TMS for more than 10 years and received FDA clearance to target OCD in 2018.

University TMS was founded by Dr. Prestley and Dr. James T. O’Neil, M.D. who have more than 10 years of combined experience in the diagnosis and treatment of all aspects of neurological disorders both in the hospital and outpatient setting. For more information, visit www.universitytmstherapy.com or call the clinic at 205-523-5618.

About University TMS
Located in Tuscaloosa, University TMS provides comprehensive treatments to effectively treat depression, addiction, and other brain disorders with non-surgical treatments, such as Deep TMS.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences